AVEO Pharmaceuticals (AVEO) Prices Offering at $7.50/Sh

January 17, 2013 9:16 AM EST Send to a Friend
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) announced the pricing of an underwritten public offering of 6,667,000 shares of its common stock at a price of $7.50 per share to the public.

All of the shares are being sold by AVEO.

The gross proceeds to AVEO from this offering are expected to be approximately $50.0 million, before deducting underwriting discounts and commissions, and other estimated offering expenses payable by AVEO.

J.P. Morgan Securities LLC is acting as sole book-running manager for the offering, with RBC Capital Markets, LLC and Canaccord Genuity Inc. acting as co-lead managers.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Equity Offerings

Related Entities

JPMorgan, RBC Capital, Canaccord Genuity

Add Your Comment